IN THE NEWS

Media Coverage

06/07/2021

Oncohost’s Focus on the Patient Offers Precision Oncology To Combat Cancer

Read More>
Nocamels

22/06/2021

Oncohost opens trial sites for study evaluating its AI proteomics profiling technology

Read More>
Bioworld

17/06/2021

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

Read More>
Pharmweb

17/06/2021

Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies

Read More>
The Times of Israel

News Releases

16/06/2021

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

OncoHost's AI-Based Proteomic Profiling Platform, PROphet®, to Serve Key Role in Host Response Evaluation of Late-Stage Disease Patients

Read More>
Cision

19/01/2021

OncoHost Secures $8 Million Series B Funding Round to Advance its AI-Powered Precision Oncology Platform

On a Mission to Match Individual Cancer Patients with the Most Effective Treatment, Investment will Expand Clinical Trials, Support Opening of a US Office and Preparation for Commercial Launch

Read More>
Cision

11/01/2021

OncoHost Welcomes Nobel Prize Winner to Scientific Advisory Board

Prof. Aaron Ciechanover Joins Host Response Profiling Company to Improve Precision Oncology and Overcome Resistance to Cancer Treatments

Read More>
Cision

09/11/2020

OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020

Study Examines Plasma-Based Proteomic Profiling as a Clinically Insightful Tool for Oncologists to Identify New Targets in Overcoming Treatment Resistance

Read More>
Cision

Videos

17/02/2021

Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer

Watch the video >
Docwirenews

31/12/2020

OncoHost – Personalized cancer therapy for more effective treatment

Watch the video >
Our Crowd

05/06/2020

PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

Watch the video >
tech-nology

04/06/2020

PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

Watch the video >
tech-nology